Transaction · 0001127602-25-007313

Hopkinson Craig C.

Hopkinson Craig C., ER, D, CMO, reported a transaction classified as exercise at Alkermes plc. involving 6866.000000 shares. Reported holdings after the transaction were 20598.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MER, D, CMO
ALKSAlkermes plc.
Filing timeFeb 28
Trade dateFeb 26, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ALKS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ALKS since 2025-02-28Filed 552 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001127602-25-007313
Restricted Stock Unit Award
Transaction date
Feb 26, 2025
Filed Feb 28, 2025, 10:16 PM · 2d delay
Shares
6.86k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
20.5k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Reduction
-14score
Filing-only score

-14

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP R&D, Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one ordinary share.

  2. F2

    Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025.

Original filing · 0001127602-25-007313
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ALKS